Recipharm AB

Amid “strong growth in demand for biologics development and manufacturing,” contract development and manufacturing organization giant Catalent, Inc has announced plans for a multi-year, $350m invest

As Moderna, Inc. receives regulatory approvals in several countries, speculation has emerged about its plans to partner with an Indian company for the manufacture and/or marketing of its COVID-19 va

The latest Medtech Insight sales ranking of the top 100 publicly-traded medtech manufacturers is COVID-19-affected for a relatively sizeable proportion of companies ̶ those whose reporting perio

The European Commission is continuing its efforts to secure COVID-19 products by signing supply deals with Gilead Sciences, Inc. for the antiviral Veklury (remdesivir) and with Janssen Pharmaceutic